Your browser doesn't support javascript.
loading
Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy.
Yang, Zhang-Ru; Liu, Mi-Na; Yu, Jia-Hua; Yang, Yun-Hai; Chen, Tian-Xiang; Han, Yu-Chen; Zhu, Lei; Zhao, Ji-Kai; Fu, Xiao-Long; Cai, Xu-Wei.
Affiliation
  • Yang ZR; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Liu MN; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Yu JH; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Yang YH; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Chen TX; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Han YC; Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Zhu L; Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Zhao JK; Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Fu XL; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
  • Cai XW; Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Transl Lung Cancer Res ; 9(5): 2059-2073, 2020 Oct.
Article in En | MEDLINE | ID: mdl-33209626

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2020 Document type: Article Affiliation country: China Country of publication: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Lung Cancer Res Year: 2020 Document type: Article Affiliation country: China Country of publication: China